Position in BNTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$17,182,891
+$3,631,092 QoQ
Shares Held
184,663
+21.1% QoQ
Ownership
0.074%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#49
of 282 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BNTX Over Time
Shares Held
Position Value (USD)
Derivatives in BNTX
reported options exposure · as of Jun 30, 2025CallValue
$0
CallShares
0
PutValue
$3,194,100
PutShares
30,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BARCLAYS PLC holds $1,706,204,586 across 455 Biotechnology names. BNTX ranks #20 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
733,274 | $364,239,192 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,192 | $159,745,957 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
1,603,136 | $127,112,653 | |
| 4 | ARGX |
Argenx SE
|
134,427 | $124,717,337 | |
| 5 | MRNA |
Moderna, Inc.
|
1,035,126 | $72,489,872 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
714,423 | $53,210,224 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
957,848 | $52,624,168 | |
| 8 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
431,753 | $42,087,281 |
All Filings in BNTX
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,182,891 | 184,663 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $13,551,799 | 152,473 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $16,478,071 | 173,089 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,603,263 | 16,257 | Shares | Sole | 2026-03-31 | |
| 2025-06-30 | $3,194,100 | 30,000 | Put | Sole | 2026-02-27 | |
| 2025-06-30 | $2,671,757 | 25,094 | Shares | Sole | 2026-02-27 | |
| 2025-03-31 | $2,048,850 | 22,500 | Put | Sole | 2026-03-17 | |
| 2025-03-31 | $2,048,850 | 22,500 | Call | Sole | 2026-03-17 | |
| 2025-03-31 | $10,830,129 | 118,934 | Shares | Defined | 2026-03-17 | |
| 2024-12-31 | $2,563,875 | 22,500 | Put | Sole | 2026-03-19 | |
| 2024-12-31 | $8,359,941 | 73,365 | Shares | Defined | 2026-03-19 | |
| 2024-12-31 | $2,563,875 | 22,500 | Call | Sole | 2026-03-19 | |
| 2024-09-30 | $9,887,956 | 83,253 | Shares | Defined | 2026-03-31 | |
| 2024-06-30 | $3,616,200 | 45,000 | Call | Sole | 2026-03-23 | |
| 2024-06-30 | $7,128,412 | 88,706 | Shares | Defined | 2026-03-23 | |
| 2024-03-31 | $3,401,073 | 36,868 | Shares | Defined | 2026-03-24 | |
| 2023-12-31 | $1,583,100 | 15,000 | Call | Sole | 2026-03-24 | |
| 2023-12-31 | $2,506,151 | 23,746 | Shares | Defined | 2026-03-24 | |
| 2023-09-30 | $3,984,805 | 36,679 | Shares | Defined | 2026-03-26 | |
| 2023-06-30 | $7,903,387 | 73,227 | Shares | Sole | 2026-03-27 | |
| 2023-03-31 | $1,868,550 | 15,000 | Call | Sole | 2026-03-30 | |
| 2023-03-31 | $12,601,374 | 101,159 | Shares | Defined | 2026-03-30 | |
| 2022-12-31 | $5,543,118 | 36,900 | Put | Sole | 2026-03-30 | |
| 2022-12-31 | $8,021,748 | 53,400 | Call | Sole | 2026-03-30 | |
| 2022-12-31 | $11,460,582 | 76,292 | Shares | Sole | 2026-03-30 | |
| 2022-09-30 | $8,820,341 | 65,394 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $22,107,502 | 148,273 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $26,061,397 | 152,799 | Shares | Defined | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||